SMB01360
1-MethylpseudoUridine
≥98% (HPLC)
别名:
1-Methyl-5-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione, N1-Methylpseudouridine
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C10H14N2O6
化学文摘社编号:
分子量:
258.23
UNSPSC Code:
41106305
NACRES:
NA.21
MDL number:
Assay:
≥98% (HPLC)
Form:
solid
Storage temp.:
2-8°C
Quality Level
assay
≥98% (HPLC)
form
solid
storage temp.
2-8°C
SMILES string
[nH]1[c]([n](cc([c]1=O)[C@@H]2O[C@@H]([C@H]([C@H]2O)O)CO)C)=O
InChI
1S/C10H14N2O6/c1-12-2-4(9(16)11-10(12)17)8-7(15)6(14)5(3-13)18-8/h2,5-8,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7-,8+/m1/s1
InChI key
UVBYMVOUBXYSFV-XUTVFYLZSA-N
General description
A key aspect of COVID-19 mRNA vaccines is the use of the modified nucleobase Methylpseudouridine to increase their effectiveness. The modified nucleobase helps cloak mRNA vaccines from the immune system, limiting their undesired immune stimulation, and in certain circumstances may also enhance the synthesis of antigens.
Application
Vaccine development
Other Notes
For additional information on our range of Biochemicals, please complete this form.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SMB01360-50MG | 04065267166360 |
| SMB01360-250MG | 04065267166353 |